TrademarkOpen
Search / United States / 97093752

Heads up: we show every live trademark, plus inactive ones from the last 5 years, in the countries listed. Data is only as fresh as each country publishes it, and some countries aren’t included yet, so a brand can be registered even if it doesn’t show here. Always check the official record before you use a name. This is not legal advice.

🇺🇸 United States · Trademark / Service Mark

A

Registered
Used for: pharmaceutical products for the treatment of cancer; pharmaceutical products for the treatment of lung cancer

Class 5 – Pharmaceuticals & supplements

Status timeline

  1. 29 Oct 2021
    Application filed
    New Application Entered
  2. 3 Aug 2022
    Assigned to an examining attorney
    Assigned To Examiner
  3. 10 Aug 2022
    Approved for publication
    Approved For Pub - Principal Register
  4. 13 Sep 2022
    Published for opposition
    Published For Opposition
  5. 8 Nov 2022
    Notice of allowance issued — statement of use required
    Noa Mailed - Sou Required From Applicant
  6. 11 May 2023
    Statement-of-use extension 1 granted
    Sou Extension 1 Granted
  7. 18 Oct 2023
    Statement-of-use extension 2 granted
    Sou Extension 2 Granted
  8. 15 Apr 2024
    Statement-of-use extension 3 granted
    Sou Extension 3 Granted
  9. 14 Mar 2025
    Statement of use filed
    Teas Statement Of Use Received
  10. 18 Mar 2025
    Statement of use accepted
    Allowed Principal Register - Sou Accepted
  11. 8 Apr 2025
    Registered on the Principal Register
    Registered-Principal Register
All 39 events
2025-04-08Registered-Principal Register
2025-04-08Notice Of Registration Confirmation Emailed
2025-03-18Allowed Principal Register - Sou Accepted
2025-03-18Notice Of Acceptance Of Statement Of Use E-Mailed
2025-03-17Statement Of Use Processing Complete
2025-03-14Teas Statement Of Use Received
2025-03-14Use Amendment Filed
2025-01-27Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
2025-01-27Attorney/Dom.rep.revoked And/Or Appointed
2025-01-27Teas Change Of Correspondence Received
2024-10-31Sou Teas Extension Received
2024-10-31Sou Extension 4 Filed
2024-10-31Sou Extension 4 Granted
2024-10-31Notice Of Approval Of Extension Request E-Mailed
2024-04-16Notice Of Approval Of Extension Request E-Mailed
2024-04-15Sou Teas Extension Received
2024-04-15Sou Extension 3 Filed
2024-04-15Sou Extension 3 Granted
2023-10-20Notice Of Approval Of Extension Request E-Mailed
2023-10-18Sou Teas Extension Received
2023-10-18Sou Extension 2 Filed
2023-10-18Sou Extension 2 Granted
2023-05-12Corrected Noa Mailed
2023-05-12Notice Of Approval Of Extension Request E-Mailed
2023-05-11Divisional Processing Complete
2023-05-11Sou Extension 1 Granted
2023-05-10Case Assigned To Intent To Use Paralegal
2023-04-24Sou Teas Extension Received
2023-04-24Teas Request To Divide Received
2023-04-24Divisional Request Received
2023-04-24Sou Extension 1 Filed
2022-11-08Noa Mailed - Sou Required From Applicant
2022-09-13Published For Opposition
2022-09-13Official Gazette Publication Confirmation E-Mailed
2022-08-24Notification Of Notice Of Publication E-Mailed
2022-08-10Approved For Pub - Principal Register
2022-08-03Assigned To Examiner
2021-11-09New Application Office Supplied Data Entered
2021-10-29New Application Entered

Goods & services by class

Class 5 Pharmaceuticals & supplements

pharmaceutical products for the treatment of cancer; pharmaceutical products for the treatment of lung cancer

First use anywhere 14 Nov 2024 · First use in commerce 14 Nov 2024

Owner details

See the official record for contact details. View official record →

Source & freshness

Source: the official United States trademark register. This record was last updated on 8 Apr 2025; the index was built on 20 Nov 2026 and covers data through 31 Aug 2026. View official record → If the two differ, the official record is correct.